Luís R.
- Country
- Portugal
- Department
- Serviço de Neurologia
Research Overview
- Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of AVP‑786 (deudextromethorphan hydrobromide/quinidine) for Agitation in Alzheimer’s Dementia
- A Multi-Center, Double-Blind, Placebo-Controlled, Phase II Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489, A Monoacylglycerol Lipase Inhibitor, as Add-On Therapy to Ocrelizumab, in Participants with Progressive Forms of Multiple Sclerosis
Data & Insights
Has run more than one trial at 4 of 125 partner sites.
Specializations
Neurological Disorders
This investigator focuses on the management of behavioral symptoms in dementia of the Alzheimer's type, with particular emphasis on therapeutic interventions for associated conditions.
- Alzheimer's Disease Management
- Behavioral Symptom Control
- Agitation Treatment
Their research explores innovative approaches to addressing behavioral disturbances in neurodegenerative conditions.
Behavioral Health
The investigator specializes in treating neuropsychiatric symptoms associated with dementia, focusing on interventions that improve patient quality of life.
- Agitation Management
- Behavioral Interventions
- Symptom Assessment
Their work encompasses comprehensive evaluation of therapeutic approaches for behavioral disturbances in elderly patients.
Geriatric Medicine
Expertise in geriatric neuropsychiatry with a focus on developing treatment strategies for elderly patients with cognitive decline and associated behavioral symptoms.
- Elderly Patient Care
- Cognitive Assessment
- Treatment Safety
The investigator's work addresses the complex needs of elderly patients with neurodegenerative conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.